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Abstract 
Background: Cardiac arrest is a devastating disorder that affects millions of people each year. 
Often having a sudden onset, cardiac arrest is almost certainly lethal if prompt treatment is not 
started. In hopes to both better understand how treatment of cardiac arrest has evolved and to 
quantitatively measure the outcome of defibrillation, multiple pieces of literature have been 
reviewed. 
Methods: Articles were found that were pertinent by using PubMed and Google Scholar. 
Literature was obtained that researched a wide spectrum of topics relating to defibrillation and 
cardiac arrest that did not focus on traumatic cardiac arrests as it is beyond the scope of this 
paper. 
Conclusion: The use of defibrillation has been thoroughly researched for decades, showing a 
reduction in mortality. Evidence-based research has continuously concluded the benefits of early 
defibrillation far outweighs any potential adverse outcome. Although algorithms used during 
treatment in cardiac arrest have varied significantly over the past 100 years, defibrillation 
remains a staple in the treatment. Governing agencies like the American Heart Association have 
consistently advocated for early defibrillation over the last few decades as more data has become 
available, specifically the data on the reduction of mortality. With the rapid adaptation of using 
Automated External Defibrillators in public locations, we can safely conclude that mortality rates 
will continue to decline. Further research is needed to determine the ideal order of interventions 
during cardiac arrest, as there is much debate on the correct ratio of compressions to ventilations 
and the use of medications to help ‘jump start’ the heart.  
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Introduction 
 The heart is one of the most amazing organs in the human body. Constantly contracting 
and providing vital blood flow to every inch of the body, it rarely fatigues in a healthy person. 
The cells that make up the heart are unique as they have automaticity, excitability, and 
contractility.1 Arguably more important than the brain, the heart begins beating only a few weeks 
after conception to the very end of our life. Most of us live our life unaware that the heart is 
beating almost every second, awake or asleep. Involuntary control and the ability of our body to 
maintain homeostasis allows us to dedicate our consciousness to other tasks, such as executing 
motor functions and interpreting sensations. Our heart will fluidly increase or decrease its cardiac 
output depending on what we demand it to do, without hesitation. This mighty workhorse of the 
human body has perhaps the most important function of all organs, so it rightfully deserves its 
own unique blood supply. No tissue can be expected to complete complex tasks without fuel, so 
thankfully the heart has its own blood supply coming primarily from the left coronary artery and 
the right coronary artery. These vessels primarily fill during diastole of the cardiac cycle, defined 
as the resting phase of the heart where the intracardiac pressures are the lowest. With patent 
lumens that maintain elasticity in the vessel walls, the blood vessels can effectively perfuse the 
cardiac muscle.2 
 Ensuring blood vessels are patent is only half of the physiology for obtaining adequate 
perfusion to the heart, as the heart must contract in an organized rhythm to pump the blood. 
There are many heart rhythms that exist, but the most common rhythm in healthy individuals is a 
sinus rhythm, where the impulse is initiated from the sinoatrial node located in the right atrium 
of the heart. This rhythm has the most efficient cardiac output, as all chambers of the heart are 
working at precise timing to create the largest stroke volume. When hypoperfusion occurs, there 
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are a variety of arrhythmias that may be present. Resulting from countless things such as a 
ruptured plaque causing blockage in a coronary artery, electrolyte imbalances, or hypothermia, 
these arrhythmias are often lethal if the pathology is not reversed quickly. The arrhythmias often 
lead to a cessation of organized contractility, resulting in cardiac arrest. Some of the common 
types of lethal arrhythmias to be present during a cardiac arrest include pulseless ventricular 
tachycardia (V-tach) and ventricular fibrillation (V-fib).3 Without treatment, these are lethal 
rhythms.  
 As described above, cardiac arrest is when the heart stops beating. Causes of this can be 
broken down into two categories, medical and trauma. In traumatic cardiac arrests, cardiac arrest 
may be due to trauma directly to the chest wall, internal or external hemorrhage, electrical 
disturbances such as lightning strikes, and much more. When caused by trauma, patient survival 
rates heavily depend on the timing and level of definitive care that is available to them. There are 
advanced procedures that can only be done by critical care providers, which may worsen 
outcomes if the traumatic arrest happens in a rural area with limited access to the providers. 
Medical cardiac arrest is often due to a ruptured plaque that becomes trapped in the lumen of a 
coronary artery, impeding blood flow. The plaque is caused by hyperlipidemia, which is 
cholesterol build-up within the blood vessels. With the lack of blood flow, the cardiac tissue 
begins to infarct, resulting in loss of contractility and ability to conduct electrical impulses. The 
percentage of obstruction, location within the vessel, and time blood flow is halted determines 
the severity of damage done to the cardiac tissue.4 Often described as a lethal event, cardiac 
arrest due to either medical causes or trauma have poor outcomes. According to the American 
Heart Association (AHA), there are more than 356,000 out-of-hospital cardiac arrests annually in 
the U.S. each year with almost 90% of them fatal. Combining in-patient and out-patient, the 
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Center for Disease Control and Prevention reports that there are roughly 800,000 Americans that 
have a heart attack each year. With a mortality rate of almost 90%, far too many lives are lost. 
Myocardial infarctions affect millions worldwide, further showing the need to investigate every 
aspect of the treatment plan. Our treatment has constantly been evolving over the past 100 years, 
but statistically it is very poor. Having worked in emergency medical services (EMS), I have 
seen many lives be cut short after both the family and EMS failed to resuscitate their loved one. 
It is for this reason that my thesis is investigating the effectiveness of one of the main treatments 
for those in cardiac arrest, defibrillation. I would like to do an analysis of the other interventions 
done during the treatment of cardiac arrest, but the discussion and research in this paper will 
primarily focus on defibrillation. 
 Current guidelines for the treatment of nontraumatic cardiac arrest is cardiopulmonary 
resuscitation (CPR). CPR has multiple components, with the primary ones being external chest 
compressions to mechanically pump the heart, and positive pressure ventilation to deliver 
oxygen to the cells. If a cardiac monitor or Automated External Defibrillator is available, a 
patient in cardiac arrest may be shocked with electricity if they are in certain arrythmias. The 
arrythmias that are coined ‘shockable’ are V-tach and V-fib, while the act of shocking is called 
defibrillation. Defibrillation delivers a set number of joules to the heart in an instant, causing all 
cells of the heart to contract at the same time. The hope is that by causing all cells to contract 
simultaneously, any abnormal rhythm that was causing the heart to contract irregularly will be 
ceased, therefore allowing a perfusing rhythm to be established. Administration of various 
medications such as epinephrine and 0.9% sodium chlorine are also indicated on current AHA 
guidelines. 
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 Treatment for cardiac arrest has been documented as early as the 16th century when Mr. 
Vesallus began resuscitating animals.5 Initially, isolated artificial respirations were the first to be 
used. This progressed to the mouth-to-mouth resuscitation, then positive ventilation methods of 
the 18th and 19th centuries. It was not until 1874 that cardiac massage began with the open chest 
method. This continued until the 1960s when closed chest compressions replaced internal cardiac 
massage. Shortly after, in 1956 external electrical defibrillation slowly became incorporated in 
the guidelines for management of cardiac arrest.5 Seven years later, the AHA incorporated 
defibrillation into the guidelines for CPR at the same time it formally endorsed CPR in 1963. 
Defibrillation remains in the current 2020 AHA guidelines and is promoted that “Early 
defibrillation…. can be targeted by resuscitation training programs to improve patient 
outcomes”.6  
 With the endless advances in CPR that have occurred in the past 200 years, defibrillation 
has stayed consistent for the past 50 plus years. With survival rates hovering around 10%, I 
question the effectiveness of it. There are numerous interventions in medicine that are performed 
for the sole reason that it has always been that way in history, yet these interventions lack any 
scientific support. My objective for this paper is to analyze the statistical evidence of the effect 
of defibrillation on patients with cardiac arrest, specifically when it is performed early in cardiac 
arrest. The patient population will be of any age group that enters nontraumatic cardiac arrest. 
Analysis of the effectiveness of defibrillation will be measured by patient mortality and the 
absence of sustained return of spontaneous circulation (ROSC) during the cardiac arrest date. 
Both inpatient and outpatient populations will be included. Based off my own personal 
experiences with defibrillation, as well as my education as a physician assistant student, my 
hypothesis is that early defibrillation will reduce mortality in patients who have cardiac arrest. 
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Background 
Action Potentials of Cardiac Cells 
 To understand the theory behind how defibrillation works, it is first necessary to be 
competent on how cells generate their own electrical charge. Cardiac cells can produce their own 
action potential, a term that means a change in voltage across the membrane. Cations and anions 
move across the cells through various channels, generating a flow of electricity which can then 
be passed down to a nearby adjacent cell. The propagation of these action potentials through gap 
junctions allows cells to communicate with one another via intercalated discs, a unique feature of 
cardiomyocytes.7 The ability to pass on a stimulus from one cell to another allows the heart to 
contract in an organized manor if the electrical pathways within the cells are functioning 
properly, and if the pacemaker of the heart is originating from what is known as the sinoatrial 
node. The generation of an action potential is a complex movement of ions that occur in a set 
sequence to allow depolarization and repolarization of the cell membrane. Appendix attachment 
#1 outlines the action of the ions within each cell. Phase 0 is when the cation sodium rapidly 
enters the cell, causing a substantial increase in positive charge of the membrane. This is known 
as depolarization. At phase 1, the sodium channels close. Phase 2 is known as the plateau phase 
and is highlighted by the slow influx of the cation calcium followed by the cation potassium 
leaving the cell. As potassium increases its rate of leaving the cell, we then enter phase 3 which 
is where repolarization of the cell membrane occurs. Phase 4 is known as the resting potential, 
where the cell membrane regains its baseline homeostasis between the concentration of sodium 
and potassium concentrations through the sodium potassium pump. The cell is then ready to 
begin phase 0 again. 
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 With the understanding of how a cell depolarizes and repolarizes, we can now correlate 
that with the physical contraction of the cardiomyocytes. When the cardiomyocytes receive a 
stimulus to depolarize, this contractility cell - primarily found in the myocardium of the heart -
responds to the sudden release of calcium by shortening the myosin and actin filaments. Leading 
to a shortening of the cell, this results in a cellular contraction. A cell by itself is only 
micrometers in diameter but combined with millions of other cells in the same organ, this 
contraction can produce a visible movement that can generate immense pressure within the heart. 
The events above define a ‘normal’ cardiac cycle within the heart. With the initial pacemaker of 
the heart being in the sinoatrial node, the cells within the atria of the heart depolarize 
simultaneously resulting in an organized contraction. The impulse is then transmitted to the 
atrioventricular node where there is a momentary pause, followed by propagation into both 
ventricles. The depolarization of the ventricles within the same time results in blood being 
ejected from the heart, measured as stroke volume.  
 When cells are failing to depolarize and repolarize in an organized pattern, arrythmias 
develop. When the irregular action of the cardiomyocytes fails to produce a sufficient stroke 
volume, this leads to an absence of pulse and is defined as cardiac arrest. If cells are depolarizing 
and repolarizing independently from one another in the ventricles, the rhythm is called V-fib. If 
there is an absence of all electrical activity, this is called asystole. If the rhythm is defined as a 
wide QRS complex that is regular, tachycardiac (heart rate greater than 100 beats per minute), 
and failing to produce a palpable pulse, the rhythm is defined as pulseless V-tach. Both pulseless 
V-tach and V-fib are coined the shockable rhythms as there is electrical activity in the heart, but 
it is scattered in its organization. The theory of defibrillation is that a large dose of electricity is 
delivered simultaneously to the cardiomyocytes, resulting in widespread depolarization. Ending 
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the arrhythmia, the sinoatrial node can hopefully re-establish an organized rhythm. The 
movement of cations and anions across the cell membrane to their baseline concentration will set 
the ideal setting for depolarization to occur. 
Methods and Timing of Defibrillation 
 The delivery of a shock during V-fib or V-tach can be performed either externally by 
placing defibrillating pads on the patient’s chest, or internally by shocking directly against the 
cardiac tissue. When internally shocked, this is accomplished by either the placement of a 
pacemaker/defibrillator that connects directly to the heart tissue or is performed using paddles by 
a surgeon during open heart surgery. The number of joules that is delivered does vary on the 
method that is used, with internal defibrillating being a fraction of the 2020 AHA guidelines of 
120-200J for a biphasic defibrillator.8 Most current external cardiac monitors are able to detect 
the amount of resistance the chest wall has, being able to adjust the voltage accordingly. For 
example, a larger number of joules will be needed to penetrate a morbidly obese patient since the 
shock must travel a further distance to the heart. This calculation allows a consistent shock to be 
delivered that is current with the provider’s ordered dose. AEDs are programmed to 
automatically deliver a set number of joules after accounting for resistance, which is 
programmed by the manufacturer. AEDs are becoming more prevalent in public places after 
several studies - that I will discuss below - have demonstrated their effectiveness in reducing 
mortality.  
 The timing of defibrillation is believed to play a substantial role in the mortality rate of 
those who present in cardiac arrest with a shockable rhythm. As I will soon investigate, we will 
see the outcomes from patients with cardiac arrest who were not defibrillated compared to those 
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who were defibrillated. For those who were defibrillated, they will further be broken down into 
early vs late defibrillation. 
Asystole and Pulseless Electrical Activity 
 In cardiac arrest, current practice is to defibrillate pulseless V-tach and V-fib. Any other 
arrhythmia in cardiac arrest is treated with medications and/or CPR. The two arrhythmias that 
are not shockable in cardiac arrest are pulseless electrical activity and asystole. Recall that 
asystole is the complete absence of all electrical activity; it is the rhythm that patients are in 
when they are pronounced dead. Since there is no electrical activity, the theory is that the cells 
will not respond to the defibrillation. In 1992, the AHA stated that delivering shocks in asystole 
was considered dangerous as there was no benefit yet a strong concern that both myocardial 
necrosis and stimulation of a parasympathetic storm could result.9  
 The stance the AHA took against shocking asystole was primarily based off a 
retrospective analysis study that was published in 1993.  Known as the countershock study, the 
study looked at six urban emergency medical services where paramedics were staffed. Patients 
with the initial presentation of asystole were grouped into two groups, one was the control that 
received no shock while the other was the experimental that received at least one defibrillation as 
soon as asystole was interpreted. The outcomes were measured in multiple areas such as return 
of spontaneous circulation and if they were discharged successfully from the hospital. The study 
concluded that of the 194 patients who were in the study, 0 of 77 patients in the experimental 
group were discharged from the hospital while 2 of the 117 in the control group were. They 
concluded that delivering a shock in asystole does not improve mortality – it may worsen 
mortality and cause further complications if the patient survives, such as additional myocardial 
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necrosis.10 For over the past two decades, the treatment of most cardiac arrests has remained 
largely unchanged. 
 A similar observational, retrospective study from 1995 to 1999 cemented the current 
guidelines of the AHA after only 3% of the participants who were shocked while in asystole 
survived to hospital discharge. Well below the national average of 8% at the time.11 With no 
large-scale studies supporting the benefit of defibrillating asystole, the guidelines set forth 
decades ago remain current as of today. 
 There are times when the heart is generating organized electrical activity that is failing to 
produce a pulse. This is called pulseless electrical activity, or PEA. In PEA, there is a disconnect 
in the electromechanical coupling within the heart. Common causes of PEA can be remembered 
as the Hs and Ts, those being the following: hypoxia, hypovolemia, hydrogen ion excess, 
hypoglycemia, hypothermia, hyper/hypokalemia, toxins, tamponade, tension pneumothorax, 
thrombosis, and trauma. The objective of this paper will not be assessing the effectiveness of 
defibrillation in trauma patients but will assess limited data of defibrillation of patients in PEA 
that is not due to trauma.   
 PEA can present itself in a wide variety of rhythms, most maintaining the ability to 
perfuse if the dissociation between the electricity and mechanical contraction is fixed. For this 
reason, defibrillation has historically served little to no role in the management of PEA as there 
is no need to ‘reset’ the rhythm of the heart. Conditions such as pseudo-PEA exist where there 
are ventricular contractions and detectable pressure in the aorta, but not enough pressure is 
generated to palpate a pulse in a peripheral artery. It could be counterproductive to attempt 
defibrillation of a patient in this setting. However, since PEA accounts for roughly 20% of 
sudden cardiac deaths outside of the hospital setting, and 68% of deaths in-hospital – majority 
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due to pulmonary embolism – I will assess the impact on mortality of defibrillating patients who 
at one point were in PEA. Current outcomes for all cardiac arrests due to PEA is an 89% 
mortality. The 2020 AHA guidelines for the treatment of PEA is epinephrine every 3-5 minutes 
with CPR, but no defibrillation.12 
 After an extensive review of various articles from Google Scholar and PubMed, I was 
unable to find any peer-reviewed articles that addressed both early and late defibrillation of a 
patient in PEA. In large part due to PEA being caused by disorders unrelated to electrical 
conduction within the heart, it is agreed upon in the medical community since the introduction of 
defibrillation that shocking PEA would not be beneficial. Treatment is dedicated to reversing the 
causes of PEA and administration of high-quality CPR with epinephrine. One metanalysis article 
highlighted the 2-5% out-of-hospital survivability of those who initial rhythm was PEA. The 
article also investigated the mortality of over one million cases where an initial non-shockable 
rhythm converted into a shockable rhythm. It concluded that those who were initially in asystole 
had higher odds of pre-hospital return of spontaneous circulation of around 47% when compared 
to those who were in PEA initially.13 
Defibrillation of Ventricular Arrhythmias  
 Early defibrillation will be defined as the delivery of a shock within 3 minutes of 
initiation of CPR. In an analysis of the advances of CPR, Wanis Ibrahim concluded that “early 
defibrillation is critical for survival…the most frequent initial rhythm is witnessed SCA is V-
fib”.14 The reasoning for the benefit of early defibrillation is the frequent presence of V-fib as the 
initial rhythm and the quick deterioration of V-fib into the non-shockable arrythmia, asystole. 
The results were clearly demonstrated by a study conducted from 1977 to 2001 in Washington. 
This observational study looked at patients age of 18 and older who had cardiac arrest out-of-
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hospital. In the study of over 12,000 patients who were treated by EMS, 4,190 were categorized 
as having a witnessed cardiac arrest with the initial arrhythmia as V-fib. The rhythm of V-fib 
was identified by technicians who were trained at the paramedic level. With prompt external 
defibrillation administered within 3 minutes, admission to the ICU was over 50% of the patients 
(N=2281). Of those who were admitted, 1,343 were discharged alive. Common reasons for those 
who had mortality while in the ICU were listed as anoxic brain injuries and heart failure. In this 
group, prompt CPR was initiated along with administration of epinephrine at 1mg.15 In the same 
study, there were roughly 2,400 patients who had an initial witnessed arrest where the rhythm 
was asystole or pulseless electrical activity. Of the 2,400, 562 were admitted to the ICU with 161 
being discharged alive. Appendix attachment #2 is the flowchart attached in the study. This study 
was conducted over the course of a 25 years and observed no drastic changes in the mortality 
rate year-to-year.  
 In-patient cardiac arrests are found to have a 15-20% increased survival rate compared to 
outpatient. These statistics are further increased if the patient has cardiac arrest during the 
daytime hours. Faster response times, trained staff at recognizing when a patient is in cardiac 
arrest, and availability of additional resources used to treat the arrhythmia all help increase the 
odds of survival. In a group of 151,071 patients who experienced in-hospital cardiac arrest, 
18.6% survived to hospital discharge without significant neurological deficits.16 These patients 
had prompt CPR and defibrillation started within the 3-minute window. When the study was 
further broken down into patients that had cardiac arrest at night versus those who had cardiac 
arrest during the day, there was a noticeable difference in mortality. During the day, survival rate 
over the 15-year study went from 16% to 25.2%, while at night the survival rate went from 
11.9% to 21.9%. It is thought the higher nurse-to-patient ratio during the night along with overall 
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decrease in work performance during nighttime hours factors in with the ability to recognize 
cardiac arrest promptly, therefore leading to a delay in treatment.  
 Early defibrillation has previously been defined as the delivery of a shock within the first 
3 minutes of initiation of CPR. It goes without saying that if the shock is delivered after 3 
minutes, it is classified as late defibrillation. Late defibrillation is currently rare in the field of 
medicine as there are no known protocols that I am aware of that call for late defibrillation if the 
patient is known to be in V-fib or pulseless V-tach. The possible exception is a severe 
hypothermic victim, but the protocols vary department to department. Reasons for late 
defibrillation are often due to delay in identifying a shockable rhythm and lack of a defibrillator 
to deliver the shock. Hospitals and EMS crews train repeatedly for cardiac arrest codes, but 
events do not always unfold like they do in a textbook. Human error, lack of resources, and 
unwitnessed arrests may all delay the delivery of the first shock. In a cohort study of 57,312 
patients from an in-patient setting with witnessed arrests, survival rate was 31.6% when initiation 
of CPR with defibrillation was over 2 minutes, compared to a survival rate of 40.5% when CPR 
and defibrillation were delivered within 2 minutes.17 To go from 31.6% to 40.5% is a 27% 
increase in survival rate, a significant value when the survival rate in general for someone in 
cardiac arrest is extremely low. See appendix attachment #3 for a chart comparing probabilities 
of survival depending on time to initiate CPR. When defibrillation was delayed over 9 minutes, 
the survival rate was as low as 17.1%. This data focused primarily on adult patients who were 
also given doses of epinephrine. But when the survivors were broken down into the timing of 
when they received epinephrine, there wasn’t a statistically significant difference between 
survival rates.17  
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 One unique finding was in pediatrics who had cardiac arrest. Unlike adults, pediatrics 
tend to have cardiac arrest secondary to respiratory arrest. Due to the easy fatigability of 
pediatrics, prolonged respiratory problems can quickly result in cardiac arrest. When a shock is 
delivered to the heart, it was found that the timing of the first defibrillation was not associated 
with both return of circulation and an increased survival rate. In a study of 477 pediatric patients, 
the survival rate of those who were first defibrillated within 2 minutes was recorded at 39% 
while those who were defibrillated after 2 minutes had a survival rate of 34%.18 Assuming that 
most of the pediatrics went into cardiac arrest due to a respiratory problem, it makes sense that 
defibrillation won’t correct the problem. The heart heavily relies on aerobic respiration, so 
prolonged hypoxic periods quickly cause dysfunction. Without supplementing oxygen, the heart 
will not be able to switch back to aerobic respiration to provide fuel for the cells that initiate 
normal rhythms. Airway and breathing management are currently listed as the first line 
intervention if a pediatric has bradycardia and is of utmost importance during cardiac arrest. In 
the United States, it is estimated that there are 6,000 pediatric cardiac arrests within hospitals 
each year.18 
AED Use 
 The use of an AED in the treatment of cardiac arrest has had profound impacts on 
survival rates. In a small observational study of witnessed cardiac arrest where V-fib was the 
initial rhythm, AED use within 5 minutes resulted in only a 33% mortality rate.19 The sample 
size was only 18 patients but is consistent with similar studies that show the benefits of prompt 
AED use. When an international team of researchers studied out-of-hospital cardiac arrests in the 
United States of America and Canada, they analyzed the cases where an AED was utilized 
promptly by a bystander. Of the 49,555 witnessed cardiac arrests, 19% of those arrests had an 
Defibrillation during Cardiac Arrest 17 
 
AED be used promptly. 66% of those victims survived to hospital discharge after being shocked 
by a bystander. When the patient had to wait for EMS to be treated with the initial shock, there 
was a 32.7% survival rate. Without a bystander using an AED promptly, more than 70% of the 
patients had a mortality.20 
 The studies that look at the use of an AED by the public are often defined as early 
defibrillation as the setting of the cardiac arrest is usually in public place, so arrests are typically 
witnessed. It is important to note that for the first several minutes, there are no advanced 
interventions being performed such as a fluid bolus or medication administration. Straight BLS 
care from bystanders was sufficient for almost two thirds of the victims. Dr. Myron Weisfeldt 
has stated that he estimates over 1,700 lives are saved in the United States each year by 
bystanders who use an AED. The statistics above demonstrate the that the use of an AED nearly 
doubles the victim’s odds of survival.  
 For every minute of delay in defibrillating a patient who is in V-fib or pulseless V-tach, 
their survival rate decreases by 10-12%.21 The retrospective study performed recently in 
Stockholm showed that when CPR was initiated prior to EMS with defibrillation, the survival 
rate was 10.5%. Without the initiation of CPR, about 4% of patients survived to be discharged 
from the hospital. The arrests were witnessed by a bystander and EMS was promptly called, but 
there was an average response time of 8 minutes.21 As referenced above, the 8-minute delay of 
EMS to arrive on scene could result in an 80-96% decreased survival rate if no CPR is being 
performed.  
Additional Factors Affecting Mortality 
 It is important to note that in addition to defibrillation, high quality CPR is vital for 
success. Highlighted in appendix attachment #4, perfusion of the coronary arteries when 
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compressions are not being performed is zero. With no blood flow to the cardiomyocytes, they 
are incapable of contracting and generating an electrical charge. The build-up of waste products 
and the switch to anaerobic respiration leads to acidosis, which accelerates the inability for a cell 
to take up products like oxygen and glucose. The American Heart Association continues to 
advocate the benefits of CPR as soon as possible due to the reduction of survival by 10-12% for 
every minute it is withheld. 
 Ventilation with oxygen is under heavy debate, as some studies conclude that there is an 
adequate amount of oxygen in the lungs and blood stream to perfuse the organs for several 
minutes after an arrest. Other studies indicate that supplemental oxygen may ensure the cells 
remained primed for when they begin functioning. It is difficult to say what will be the future of 
ventilations during CPR due to the lack of studies that isolate a change in only one of the core 
interventions – compressions, ventilations, defibrillation, and medication administration such as 
epinephrine. One study that did an in-depth analysis of ventilation during CPR concluded that 
assisted ventilation may not always be beneficial. It may worsen outcomes by decreasing the 
times doing compression and leading to hyperventilation. Hyperventilation can result in 
displacement of carbon dioxide and excessive air entering the stomach, both harming the patient. 
With air entering the stomach, the pressure that builds on the upper esophageal sphincter may 
cause the back of gastric contents, resulting in vomiting and aspiration of the contents. The lack 
of carbon dioxide leads to an altered pH level within the body, further causing problems with the 
diffusion of oxygen into the tissues.22 
 Epinephrine is thought to improve coronary and cerebral perfusion by improving 
contractility of the heart and systemic vascular resistance. Its use has been controversial since its 
introduction but has currently become a staple in the 2020 AHA guidelines for cardiac arrest. 
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The theory is that the administration of a medication like epinephrine will help improve the 
chance of return of spontaneous circulation, also known as ROSC. This comes at a risk as the 
potential harmful effects of epinephrine on intracranial pressure and damage to the 
cardiomyocytes is not fully researched.23 The adverse reactions are often difficult to measure 
because if they are present, we are unsure if it is due to the administration of epinephrine, or the 
time spent in cardiac arrest that led to a buildup of toxic byproducts in the brain and heart. Still, 
studies have demonstrated that epinephrine is associated with a significant higher likelihood of 
return of spontaneous circulation at 23.1%, and survival to hospital discharge at 36.3%.23 In the 
studies that look at epinephrine, many concluded that although epinephrine is beneficial for 
achieving return of spontaneous circulation, it had little to no effect on improving neurological 
outcome.24 
 It appears that the use of epinephrine, adequate ventilation, and high-quality 
compressions all decrease mortality during cardiac arrest. Because these are now all considered 
standard of care in any cardiac arrest, it is difficult to determine to what extent one of these 
interventions has on mortality. Add in the patient’s underlying medical illnesses and the effect of 
defibrillation on mortality, it is easy to see why the studies, although present and very thorough 
with their research, struggle to eliminate all other confounding variables. 
Potential Problems With Defibrillation 
 Like anything in medicine, everything comes with a chance of risks. Perhaps the most 
studding problem I encountered came from the lack of experience of the trained hospital staff. In 
a prospective observational study in Italy that assessed the knowledge level health care 
professions regarding CPR and early defibrillation, over 55% of the surveyed doctors and nurses 
reported they did not feel comfortable using a defibrillator.25 The large percent is a shocking 
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number as it is the expectation and law for every health care provider to be Basic Life Support 
certified. The staff felt their skills on both CPR and defibrillation were not appropriate. This lack 
of knowledge and experience is also found out-of-hospital in nonmedical professionals. 
Although more justifiable, the outstanding lack of knowledge of basic CPR and access to AEDs 
may be drastically increasing the mortality by delaying the delivery of a shock within 3 minutes 
of cardiac arrest. When a bystander is both knowledgeable about CPR and able to use an AED, 
there is a double survival rate with hospital discharge. (Site D) Showing a promising step in 
reducing the mortality of cardiac arrest, bystander CPR with AED use has statistically proven its 
benefits. The major problem is the lack of public access to defibrillation in the out-of-hospital 
cardiac arrest patients. Fewer than 5% of out-of-hospital arrests have the use of an AED by a 
bystander.26 Having worked on multiple rural EMS services, there is a saying that “time is 
tissue”  when CPR is not being performed. The response time from station to scene time at 
Colfax Rescue Squad where I work is far beyond the 3-minute period that defibrillation has been 
proven to work. Without trained bystanders, mortality will continue to be high for anyone that 
has cardiac arrest without prompt care.  
 Bystanders and even medical professionals who are trained in CPR have continuously 
expressed concern of accidental shocking of themselves while they defibrillate the patient. It is 
logical to think that if the defibrillation has enough joules to reset someone’s heart, it would be 
capable of transmitting a that same amount of energy through an extremity of the person 
performing CPR if they happen to be touching the patient during the shocking period. In a 2016 
study that looked at the utilization of hands-on-defibrillation, it was found that “nitrile pads and 
neoprene gloves prevented 99% of shocks detectable by the caregiver”. Of the 1% who did feel 
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the shock, only a brief tingling sensation and paresthesia was noted by the caregiver for up to 24 
hours.27 
 An extensive concern with the use of defibrillation is the adverse reaction of having the 
rhythm of V-tach or V-fib turn into asystole and myocardial necrosis.28 Delivering enough of a 
charge to cause all cardiomyocytes to depolarize yet not enough damage that causes permanent 
damage to the heart is a complex problem that has no definitive answer. There are many 
suggestions, notably from the AHA that states a charge of 200J for defibrillation of biphasic 
monitors does not provide measurable myocardial necrosis, but the studies are often found to be 
inconclusive as it is difficult to determine if the myocardial necrosis came from the lack of blood 
flow to the heart during the cardiac arrest period, or if it came because of defibrillation. The 
excess charge from the defibrillation may alter the conformation of biomolecules, therefore 
permanently altering the structure of them. Combined with the disruption of the cell membrane 
from artificially altering the placement of the ions, it is easy to see how excessive defibrillation 
can cause myocardial damage.  
 The hope after defibrillating is the sinoatrial node will start initiating impulses again, 
causing the heart to beat in a normal sinus rhythm. The worst outcome of defibrillation is if the 
rhythm changes from the shockable V-tach/V-fib into a non-shockable rhythm such as asystole. 
Asystole occurs usually as a deterioration of the initial non-perfusing ventricular rhythms and 
represents the cessation of all electrical activity in the heart. Victims who present and deteriorate 
to asystole have a hospital discharge rate of 0-2%.29 It is this breathtaking low number that may 
scare some providers. Even when done properly, defibrillation can cause the rhythm to convert to 
asystole as all cells within the heart have just depolarized; they are incapable of depolarizing for 
some time until they have repolarized. This time period can vary from milliseconds to seconds to 
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being permanent. If no cell or group of cells in the heart initiate the rhythm after defibrillation, 
then there will be an absence of all electrical activity. With this being said, it is still crucial to 
remember that the patient was previously in a lethal arrhythmia if they needed to be defibrillated.  
 As stated above, the act of no defibrillation on these lethal arrhythmias proved to have a 
much higher mortality rate than if we were to defibrillate. With no resuscitation efforts such as 
CPR and defibrillation, V-fib and pulseless V-tach are almost certain to deteriorate into asystole 
as the cardiomyocytes continue to die due to lack of perfusion.14 In medicine, the golden rule is 
to do no harm. Many times, this translates to picking the solution that does the least harm with 
the most benefit for the patient.  
Methods 
 Several databases were used to search for literature that addressed my thesis question. 
The primary databases that were used are Google Scholar and PubMed, but multiple peer-
reviewed articles were also found using Science Direct and UpToDate. The literature searches 
were completed between June 15th and July 9th, 2021. Key words that were used to retrieve 
relevant literature in the search for articles were “Defibrillation”, “Return of Spontaneous 
Circulation”, “Cardiac Arrest”, “Treatment of Cardiac Arrest”, and “Cardio-pulmonary 
Resuscitation”. Although there were thousands of articles for me to select from, I quickly 
narrowed them down by focusing on the articles that were published within the past 3 years. 
Some articles were included that were published further that 3 years ago as it was necessary to 
better understand the progression of how cardiopulmonary resuscitation changed over the years. 
The abstract of articles was used to help determine the appropriateness towards my thesis 
question. Articles with limited text were excluded from this paper, as were those that are written 
in languages other than English due to the inability to accurately translate them. Several articles 
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that did not have full text available online had to be requested through the Augsburg Lindell 
Library.  
 The inclusion criteria included articles that focused on treatment of nontraumatic cardiac 
arrest in all ages, if mortality was measured, and if the article listed the arrhythmia that was 
being treated. The literature articles incorporated many types of studies which immensely helped 
strengthen this paper. The types of studies included are retrospective and prospective 
observational studies, prospective interventional trials, randomized controlled trials, meta-
analyses, systemic reviews, and clinical practice guidelines of resources like UpToDate and 
American Heart Association. Each study and its data were reviewed for its accuracy and 
pertinence to my thesis. 
 Data interpretation was performed by the author of this paper, with all relevant data being 
summarized in text. Also included are the graphs and tables which are attached in the appendix 
section. In-text citations are used in this paper to help guide the reader in identifying where 
factual information was derived from. Each table and article that is contained in this paper has 
been cited in the reference section in compliance with AMA style. No expert interviews were 
conducted.  
Discussion 
 The literature discussing the treatment of cardiac arrest has been thoroughly researched 
for decades. The rise in acute coronary syndrome in the United States correlates with an increase 
in cardiac arrests each year, making the literature more important. Determining the ideal 
treatment is key to reducing mortality in those who have this often lethal disorder. Defibrillation, 
high quality CPR, and epinephrine administration continue to be integrated in the current AHA 
guidelines for cardiac arrests who are in V-tach or V-fib. Finding the ideal balance of these three 
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interventions, along with addition medications and procedures that could reduce mortality, 
requires evidenced based medicine over decades.  
 As discussed by Luo S, Zhang Y, et al, defibrillation of asystole is considered dangerous 
as there has statistically been no decrease in mortality while causing myocardial necrosis and a 
parasympathetic storm. Oliver TI, et al supported harmfulness of defibrillation in asystole after 
publishing that 0% of the patients in the experimental group that received at least one 
defibrillation while in asystole survived to discharge the from the hospital. The national average 
for survival in patients with an initial rhythm of asystole was 8% at the time. The known 
pathophysiology of asystole supports the evidence showing the impracticality of this intervention 
since there is no electrical activity to begin with. Unfortunately, the studies failed to state if late 
and/or early defibrillation were performed. 
 The limited statistical evidence collected for the treatment of PEA makes it difficult to 
incorporate this arrythmia amongst the other causes of cardiac arrest. Having concluded that 
defibrillation has no place in the treatment of PEA shortly after the AHA was founded, there 
were no studies finding data that addressed defibrillation in those with PEA. Luo S, et al did 
discuss the mortality after defibrillation in those who had an initial rhythm of PEA that converted 
to a shockable one, finding that only 2-5% of them survived to be discharged from the hospital. 
Patients who presented in asystole that were then defibrillated once the rhythm converted to a 
shockable one had a 47% survivability rate. 
 The core of this literature review revolved around the use of defibrillation, specifically in 
those with V-tach and V-fib who were shocked either “early” or “late”. The strongest statistically 
relevant article was by Ibrahim WH, et al who concluded that defibrillation within 3 minutes of 
cardiac arrest resulted in only a 50% mortality. This study was supported by the Uchenna R. 
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Ofoma, et al study where they observed a 15-20% increased survival rate in patients who 
arrested inside a health care facility. The early defibrillation by trained staff separated them from 
the control groups of out-patients. The immediate recognition of cardiac arrest with defibrillators 
within walking distance allow patient’s a considerable reduction in mortality. When care and 
defibrillation is delayed, the odds of survival also diminish. Bircher NG, et al demonstrated this 
with a 27% increase in mortality when defibrillation was delayed by over 2 minutes when the 
initial rhythm was either V-tach or V-fib. All literature except for one reviewed demonstrated 
statistical evidence that early defibrillation of shockable rhythms resulted in a drastic reduction 
in mortality, with greater reduction being obtained the sooner defibrillation is administered. The 
exception was in a pediatric trial where the increase in mortality as defibrillation was 12% after 
defibrillation was delayed by more than 2 minutes. This slight increase in mortality is surprising 
after finding that for every minute of delay in defibrillating an adult patient who is in V-fib or 
pulseless V-tach, their survival rate decreases by 10-12%.  
 Ross A. Pollack, et al demonstrated the effectiveness of AEDs in their role to reduce 
mortality. A 33% mortality was recorded when an AED was used within 5 minutes of a 
witnessed cardiac arrest. Those who survived had over a 66% chance to successfully discharge 
from the hospital. Without the use of an AED, mortality rate was 67.3% when the patient had to 
wait for EMS to arrive on scene to deliver the first shock.  
 Only being mentioned in one article, I believe that more thought should be given to the 
potential of misinterpreting fine V-fib as asystole. I’ve seen firsthand new paramedics 
misdiagnosis fine V-fib as asystole, leading to the wrong treatment algorithm. After seeing the 
benefits defibrillation has on reducing mortality, it is crucial that the medical society ensures that 
each rhythm is interpreted correctly. A new method to help solve this potential problem is the 
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use of ultrasound during cardiac arrest. Easy to use and noninvasive, ultrasound can reliably pick 
up cardiac movements in real time.  
Conclusion 
 The management of patients in cardiac arrest is constantly changing as new evidenced-
based practice is being taught. However, defibrillation has remained a core intervention in 
certain cases as it has proven its reduction on mortality in numerous clinical trials. Large 
governing bodies such as the AHA have stated that early defibrillation combined with high 
quality CPR provides the best outcome for a patient who is in cardiac arrest. The presence of 
AEDs in public places has further reduced overall mortality, speaking of the importance to have 
bystanders trained on how to correctly use it.  
 Despite the advancements that have been made, the mortality rate remains almost 90%. 
Defibrillation is proven to reduce mortality, but I am unsure if solid evidence exists for the other 
interventions performed during CPR, such as the administration of epinephrine and 
antiarrhythmics at their current dosing and frequency, or the ratio of compressions to 
ventilations. Further research should be conducted on these interventions to find the ideal 
treatment. Making every high schooler become CPR certified prior to graduation and increasing 
public access to AEDs would also help decrease mortality while introducing students to the field 
of medicine at a young age. The increase in number of medical providers, from EMTs to doctors, 
would help save some of the millions of lives lost each year to cardiac arrest. Preventing 
coronary artery disease by reducing risk factors and increasing patient education would further 
drive mortality rates down. If the history of medicine has taught us anything, it is that the future 
practice of medicine will be far different than our present practice. 
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Appendix 
Appendix #1: Cardiac Muscle Action Potential.7 
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Appendix #3: Survival Probability vs Time to Initiate CPR.21 
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